After presenting at the 2023 HIV Cure & Immunotherapy Forum held alongside International AIDS Society (IAS) 2023, the 12th IAS Conference on HIV Science, in Brisbane, Dr Ming Lee was invited to appear on the Sexually Transmitted Infections (STI) Podcast. The episode, entitled IAS23 Conference Feedback in Brisbane, Australia in July 2023, discussed some of […]
Dr Ming Lee (RIO Trial physician) talk on bNAbs in clinical trials at IAS 2023, Brisbane.
Our RIO Clinical Research Fellow at Imperial College London and Imperial College Healthcare NHS Trust, Dr Ming Lee, was invited to speak at the 2023 HIV Cure & Immunotherapy Forum held alongside International AIDS Society (IAS) 2023, the 12th IAS Conference on HIV Science, in Brisbane, Australia. The talk included an overview of the RIO […]
Prof Sarah Fidler in Imperial College London podcast for Pride Month
13 June 2023 To celebrate Pride Month, Imperial College London has published a series of podcasts exploring stigma and the impact it has on mental health for people living with HIV. Our RIO Chief Investigator, Prof Sarah Fidler, discussed long-term treatment options with a view to improving the quality of life for people living with […]
RIO Trial featured in The Body’s review of HIV Research at the end of 2022
Dec. 21, 2022 by Tim Murphy “A T cell (red) that’s been infected with HIV produces many copies of the virus (blue), as shown in this colorized transmission electron micrograph. HIV cure research continues to seek out ways to end this process once and for all.” Photo: NIAID “It seems as though a day did […]
RIO’s Prof Sarah Fidler featured in a news piece celebrating 25 years of Imperial’s Faculty of Medicine and trailblazing HIV and AIDS research
1st Dec 2022 by Genevieve Timmins, Imperial College London The launch of Imperial’s Faculty of Medicine in 1997 coincided with a new era in HIV/AIDS treatment and research. Just prior to its creation came the groundbreaking revelation that combining three antiretroviral drugs could drastically improve the prognosis of people living with HIV. The subsequent rollout […]
The RIO Trial on World AIDS Day
1st December 2022 On this #WorldAIDSDay2022 we would like to thank all our participants for all their commitment and time for the #RIOTrial. The trial is still open for recruitment and midway to full enrollment. We look forward to sharing exciting updates from the study soon! […]
Long-awaited results of the eCLEAR study are out showing the impact of the bNAb ‘3BNC117’ in people with detectable viraemia
17 Oct 2022, Nature Medicine The eCLEAR study published their results in Nature Medicine in October. This study combined the use of 3BNC117, which is a broadly neutralising antibody (bNAb), with a potent latency reversing agent, romidepsin, to reduce the HIV reservoir in individuals starting antiretroviral treatment (ART) for the first time. The study was […]
Professor Sarah Fidler on BBC’s Newsnight programme
4th July 2022 Professor Sarah Fidler was interviewed on the BBC’s Newsnight programme last night together with the CEO of the Terrence Higgins Trust, Ian Green. It has been 40 years since the death of Terrence Higgins who was the first person in the UK to die of an AIDS-related illness. The interview covered important […]
Professors Sarah Fidler and John Frater on the bNAb vaccinal effect
Current Opinion in HIV and AIDS – May 2022 – Volume 17 – Issue 3 Our RIO Trial Chief Investigator Professor Sarah Fidler and Protocol Co-Chair Professor John Frater have contributed to a recent discussion piece on the vaccinal effect of the HIV bNAbs. Please read the article here, which was published in the May 2022 issue of the […]
Professor Sarah Fidler in the Shot & Chaser podcast
June 7, 2022 Listen to the latest Shot & Chaser podcast with our RIO Trial Chief Investigator, Professor Sarah Fidler, where she discusses the RIO Trial in the context of cure. Please follow this link to the podcast. […]
